Contents

Search


bosentan (Tracleer)

Indications: -> treatment of pulmonary hypertension (FDA approved 2001) Monitor: - liver function tests baseline & monthly for duration of treatment [2,3] Adverse effects: - hepatotoxicity [2,3] Mechanism of action: -> endothelin inhibitor Notes: Manufacturer: Actelion

Interactions

drug interactions drug adverse effects of antihypertensive agents

Related

endothelin

General

endothelin receptor antagonist

Database Correlations

PUBCHEM correlations

References

  1. Prescriber's Letter 9(2):S1 2002
  2. FDA Medwatch http://www.fda.gov/medwatch/safety/2006/safety06.htm#Tracleer
  3. Prescriber's Letter 17(7): 2010 Recommended Lab Monitoring for Common Medications Liver Function Test Scheduling Detail-Document#: 260704 (subscription needed) http://www.prescribersletter.com